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ABSTRACT
The dimer initiation site/dimer linkage sequence
(DIS/DLS) region of the human immunodeficiency
virus type 1 (HIV-1) RNA genome is suggested to
play essential roles at various stages of the viral
life cycle. Through a novel assay we had recently
developed, we reported on the necessary and suffi-
cient region for RNA dimerization in the HIV-1 virion.
Using this system, we performed further detailed
mapping of the functional base pairs necessary
for HIV-1 DLS structure. Interestingly, the study
revealed a previously unnoticed stem formation
between two distantly positioned regions. Based
on this and other findings on functional base
pairing in vivo, we propose new 3D models of the
HIV-1 DLS which contain a unique pseudoknot-like
conformation. Since this pseudoknot-like conform-
ation appears to be thermodynamically stable,
forms a foundational skeleton for the DLS and
sterically restricts the spontaneous diversification
of DLS conformations, its unique shape may con-
tribute to the viral life cycle and potentially serve
as a novel target for anti-HIV-1 therapies.
INTRODUCTION
The genome of a retrovirus such as human immuno-
deﬁciency virus type 1 (HIV-1) is a single-stranded,
positive-sense RNA. The viral genome always exists as a
dimer in virions, and they interact non-covalently, as
heating easily dissociates puriﬁed dimeric genomes into
monomers. It has been suggested that the genome dimer-
ization plays an important role at various stages of the
viral life cycle, including genome packaging and reverse
transcription, as well as genome recombination processes
involved in viral diversiﬁcation (1–3). Electron microscopy
studies have suggested that the 50 region of both viral
RNAs contains a primary contact point and is referred
to as the dimer linkage structures (DLS) (4–6). Thus far,
there have been a certain number of reports regarding
in vivo HIV-1 RNA dimerization (7–11) and we are grad-
ually accumulating further knowledge and insight. The
presumptive primary DLS of HIV-1 has been mapped to
a region near the major splice donor and biochemical
analysis indicates that the DLS probably consists of
multiple stem–loop structures (12). Within the DLS,
stem–loop 1 (SL1) has been regarded as the most import-
ant region, which forms a stem–loop structure with a
hairpin loop containing a 6-nt palindromic sequence
(13). The dimer formation would occur through a
kissing hairpin mechanism by which the two RNAs
would form an initial loop–loop contact based on comple-
mentary anti-parallel base pairing at the SL1 loops (14).
So far, partial structures within DLS, such as SL1, 2, 3
and 4, have been solved and characterized to some extent
(15–24). Furthermore, an in vitro NMR structural model
of the entire HIV-1 DLS was released recently (25),
stimulating increasing demand for the further detailed
structural information about the in vivo structure of
the HIV-1 DLS.
We previously developed a novel system to assess the
DLS operation within the HIV-1 virion and identiﬁed the
region that is necessary and sufﬁcient for HIV-1 genome
dimerization in the virion (26). Using this system coupled
with loss- and gain-of-function studies using site-directed
mutagenesis, we performed a more detailed mapping of
the functional base pairs required for HIV-1 genome
dimerization and replication. Interestingly, the study
revealed a previously unnoticed base-pairing interaction
between two distantly positioned 5nt in the DLS (GCG
UC-GACGC duplex). Based on this and other ﬁndings,
we propose a new secondary structure model of a minimal
DLS element that contains a unique pseudoknot-like con-
formation, as well as two 3D structure models of the
DLS element, which are consistent with current and
previous experimental ﬁndings.
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Constructs
The replication-competent HIV-1 pro-viral clone pNL4-3
(subtype B) (27), its Env mutant pNLNh (1), or its deriva-
tive DDNLp42 (renamed as DDNd2) (26) were used
as progenitors for the mutant constructs described
below. Mutant plasmids were constructed with standard
methods. To make the construction of recombination
clones more convenient, several base-substitution muta-
tions were introduced into the N-terminal region of
the matrix (MA) gene of pNLNh to create the SgrAI
recognition site (pNLAINh) (2). Although the one
amino acid substitution (Ser to Thr) at the ninth
position of MA in pNLAINh was inevitably introduced
as a result of these base substitutions, similar levels of
virion production were observed in both cells transfected
with pNLAINh or pNLNh, suggesting that the effect of
the mutations on particle formation was negligible. Precise
details of the plasmid construction are found in the
Supplementary Methods and Supplementary Table S1.
DNA transfection
In total, 293T cells (28) ( 3 10
6) were seeded on dishes
(diameter, 100mm) the day before transfection with
plasmid DNA (5mg) by means of the calcium phosphate
precipitation method (29). The day after transfection,
the supernatant was replaced with fresh medium.
Virus infection
At 48–72h post-transfection, the media was centrifuged
and the supernatant was used for infection into MT-4
cells. Equal amounts of p24 were inoculated into the
cells. The supernatants of the MT-4 were harvested
every 3 or 4 days for multiple replication assays. About
10ml of each cell supernatant was subjected to exogenous
RT assay as described previously (30).
Isolation of RNA from virions
At 48–72h post-transfection, virus particles were collected
from the media as described elsewhere (31). The physical
virus titer was determined with an ELISA assay kit for
quantitation of CA-p24 (ZeptoMetrix, Inc., Buffalo, NY,
USA). To isolate RNA from particles, virions were dis-
rupted by the addition of 1% sodium dodecyl sulfate
(SDS) and treated with proteinase K (300mg/ml) at
room temperature for 60min, followed by TE-saturated
phenol/chloroform extraction, chloroform extraction and
ethanol precipitation.
Northern blotting analysis
Pelleted RNA was resuspended in T-buffer (10mM
Tris–HCl pH 7.5, 1mM EDTA, 1% SDS, 100mM NaCl
and 10% formamide) and the thermostability of the
dimeric viral RNA was determined by incubating RNA
aliquots for 10min at the prescribed temperatures (32).
RNA folding under native conditions is regarded to be
achieved by incubation at 25 or 35 C, since viral RNA
was always treated at or below room temperature during
puriﬁcation. RNA electrophoresis on native agarose gel
and northern hybridization analysis were performed as
described elsewhere (1). Plasmid T7pol (32) was used to
synthesize a complementary RNA probe for northern
hybridization. In experiments designed to assess the
conversion of dimers to monomers, relative amounts of
both RNA species were quantitated by phosphorimager
analysis (Fujiﬁlm Co., Tokyo, Japan) to determine ratios
of dimers and monomers. Since the ratio of monomer
content to total RNA of virion varied from experiment
to experiment, we calculated the ‘D–value’, which is the
index of the dimerization efﬁciency, for the fair validation
(Figure 1). The calculation of D-value was described
elsewhere (1). In short, we made an Equation (1) to give
an index value of dimer formation efﬁciency (D) for each
of the mutants, to map the functional DLS area fairly and
squarely.
D ¼ð M   WÞ=ðB   WÞ
Where W, B and M represent ratios of monomer content
to total RNA of virions produced from wild-type, DDNd2
and each DDNd2 derivative mutant construct at room
temperature, respectively. The D-value of the wild-type
is 0 and that of DDNd2 is 1. When the combination of
mutants severely affects dimer formation, the monomeric
genome content of the virion is reduced and D becomes
close to 0. Thus, the D-value was expected to represent the
magnitude of the effect of the DLS mutation in virions.
Selective 20-hydroxyl acylation analyzed by primer
extension analysis
RNA selective 20-hydroxyl acylation analyzed by primer
extension (SHAPE) analysis was performed as described
elsewhere (33,34) with minor modiﬁcations. Ex virion
HIV-1 RNA was applied for the analysis and RNA
reactivity to the chemical modiﬁcation reagent at speciﬁc
sequence positions were calculated. Experimental details
are found in Supplementary Methods.
Construction of 3D structural model of the DLS dimer
We predicted the 3D structure of dimer of the DLS by the
following procedures. First, we predicted secondary
structure of the DLS monomer by using bioinformatics
algorithms without using information on the base
pairing predicted from present mutation study. We
explored most likely base pairs in the DLS monomer by
CentroidFold (http://www.ncrna.org/centroidfold) (35,36)
without restraints of any base pairs (Supplementary
Figure S4, red lines). We subsequently explored other
likely base pairs by MC-Fold (http://www.major.iric.ca/
MC-Pipeline/) (37), with constraints of the most likely
base pairs as predicted by CentroidFold (Supplementary
Figure S4, green lines). The explored base pairs included
all of the base pairs that were predicted from data with our
RNA dimerization assay. Next, using the secondary struc-
ture information of the DLS monomer, 3D structural
models of the DLS monomer were predicted with
MC-Sym (37). We only considered authentic base pairs,
A-U, G-C or G-U pairs, at the ends of each stem to
minimize instability of the structure. With these
Nucleic Acids Research, 2012,Vol.40, No. 11 5013constraints, we could obtain only two monomer models,
since pseudo-knot like conformation in the DLS
restrained conformational ﬂexibility of the monomer.
Then, dimer structures were constructed by superposing
the 3D structure of SL1 in the predicted monomer
with that in the reported structure of SL1 dimer [PDB
code: 2D19 (24)]. For the superposition, we ignored
intra-molecular base pairs at the dimerization site in SL1
to preserve inter-molecular base pairs critical for the RNA
dimerization. Last, energy minimization was achieved for
the constructed dimer structures, by 10000 steps of the
steepest descent method and the subsequent 10000 steps
of the conjugated gradient method. At the minimization,
energy calculation was performed with parmbsc0 force
ﬁeld (38) and generalized born solvent energy function
(39) by sander module in AMBER9 (40).
RESULTS
In vivo evaluation of the branched multiple hairpin
formation of HIV-1 DLS
In our previous report, we identiﬁed the region that is
necessary and sufﬁcient for HIV-1 genome dimerization
in the virion (d2 fragment) utilizing a unique analysis
system that we developed (Figure 1A and B) (26). The
mapping of the DLS has been performed based on the
predicted secondary structural model which includes
the PBS stem–loop and SL1-4 (12). So far, several
reports suggested that the HIV-1 genome leader region
could form a possible structure called branched multiple
hairpin (BMH) (41,42). In this model, the 50 junction
sequence formed a stem structure with a gag AUG
sequence that has been suggested to form the base of
SL4. As shown in Figure 2A, gag AUG region could
interact with either the immediate downstream region to
form SL4, or with the 50 junction to make the BMH form.
The BMH model has been previously validated by in vitro
experiments (41,42), and our in vivo DLS studies included
all sequences required for proper BMH formation. To
test whether the BMH or SL4 formation occurs in virus
particles, several mutants derived from DDNd2 (renamed
from DDNLp42) (26) were constructed. A series of
mutants were constructed by introducing several base
substitutions in the inserted d2 fragment of DDNd2
(Figure 2A). The mutant M5 was constructed to disrupt
an interaction between AUG and the 50 junction by
introducing a mutation in the 50 junction. M5M3 was con-
structed to restore the AUG–50 interaction and to disrupt
SL4 formation by an additional mutation in the AUG
region. M3comp was constructed to force SL4 formation
through mutations in both stems of SL4. The mutants
d3.5 and M4 contained an 8-base deletion and a 3-base
substitution at the 30-end of DLS, respectively, to elimin-
ate SL4 formation. The mutants d3.5 and M4 did not
make any notable contributions to BMH structure forma-
tion (Figure 2B). The viral RNAs from these mutants
were analyzed by native northern blotting. As shown in
Figure 2B, all of the genomic RNA from the mutants
formed monomeric genomes inefﬁciently in comparison
with that of the wild-type (WT). These data indicated
that neither the BMH nor SL4 forms sufﬁciently repre-
sented the functional structure of HIV-1 DLS. This
Figure 1. System utilized to map the functional sequence of HIV-1 DLS. (A) Schematic representation of the constructs utilized. On the right, bold
lines represent viral genomes. Ws represent DLS at native and ectopic positions. Ectopically inserted DLS (d2 fragment) expands from nucleotide 557
to nucleotide 806 (NL4-3 DNA sequence, Genbank Accession no. M19921.2) with deletions of partial PBS stem–loop and SL2. (B) Schematic of the
genome dimerization assay. Bold lines represent viral genomes. Ms represent d2 fragments with mutations. Native northern blots of viral RNA of
DDNd2 derivatives are shown on the right. Black and white arrowheads indicate the dimeric and monomeric viral genome, respectively. Where the
size of the arrowheads indicate the relative strength of the signal. The temperatures of RNA incubation are shown.
5014 Nucleic Acids Research, 2012,Vol.40, No. 11observation strongly suggested that the actual functional
active form of DLS in vivo might be an entirely novel
secondary structure.
Discovery of a novel interaction within the DLS for
HIV-1 RNA dimerization and replication
We focused our analysis on the functional signiﬁcance of
the RNA sequence at the 30-end of the DLS on the HIV-1
life cycle, since a complete deletion or subtle base
substitutions of the 30 half of SL4 severely crippled the
dimerization ability of DLS (Figure 2, M4 and d3.5).
When comparing the DLS sequences from nine HIV-1
subtypes and SIVcpz, we found highly-conserved comple-
mentary sequences immediately upstream of the SL1 stem
(GACGC) and at the 30-end of the DLS (GCGUC)
(Figure 3A, green and blue boxes). To assess whether
the two complementary sequences can form a functional
duplex for RNA dimerization and support HIV-1 replica-
tion, mutational analysis was performed. As the GCGUC
sequence is in Gag frame, several silent mutations at GCG
UC and their respective restorative substitutions at GAC
GC were introduced into the d2 fragment of DDNd2
to observe the roles of RNA sequence on genome dimer-
ization (Figure 3B). Notably, the dimerization abilities
of the silent mutants were markedly reduced and the sub-
sequent compensatory substitutions restored its ability, to
a level comparable with that of WT (Figure 3C and
Supplementary Figure S2). The same mutations were
introduced into the backbone of the HIV-1 pro-viral
construct (pNLAI43) and similar defects and subsequent
restorations were also observed in the viral replication
process (Figure 3D). These data strongly suggest
that this duplex formation (GACGC-GCGUC duplex)
occurs within the virus and grossly affects its activity
in vivo.
Recently, in vivo HIV-1 RNA secondary structures have
been described in several reports, based on the results of
chemical or enzymatic probing, such as SHAPE analysis
(10,33,34). In these presented structural models, there
were no traces of the GACGC-GCGUC duplex. To get
further information about the duplex by chemical
probing, we have performed SHAPE analysis with
Figure 2. Evaluation of previously proposed HIV-1 DLS models. (A) Schematic representations of the alternative forms of DLS (12,41,42). The SL4
form contained a stem–loop at 30-end, whereas the BMH form contained a stem–loop at 50-end. (B) Virion RNA proﬁles detected by northern
blotting in a native agarose gel. Viruses were prepared by transfection of 293T cells with the wild-type (WT; pNLNh) virus or its derivative mutants.
Aliquots of RNA extracted from virions were resuspended in T-buffer and incubated for 10min in parallel reactions. The temperatures in which
aliquots were incubated are indicated. Below the blot, schematic ﬁgures of the mutants and their dimerization efﬁciency (D-Value) are shown. Results
are the average of three independent experiments with standard error of mean (SEM).
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(NLAIS4m1, NLAIS4m1PK and NLAIC236G) along
with the wild-type virus was calculated for each base in
the duplex and adjacent U5-AUG duplex (Supplementary
Figure S3A and B). Consistent with the previous SHAPE
reports, the overall GACGC-GCGUC duplex reactivity
was very low and not signiﬁcantly affected by the muta-
tions to destabilize (C236G and S4m1) and to restore the
duplex (S4m1PK). Although it was very faint, there were
some changes in reactivity, notably at GCGUC sequence
exclusively in the destabilizing mutant. In addition,
coinciding with the results from dimerization assay
above (Figure 4B) and previous SHAPE assays, the
50-end of DLS (U105-U107) was relatively reactive,
suggesting the absence of base paring. At the same time,
similar to the GACGC-GCGUC duplex, the overall
U5-AUG duplex reactivity was not signiﬁcantly affected
by the mutations.
Conﬁrmation of reported stem formations within
DLS in vivo
We next closely examined the roles of several stem
formations within the DLS that have been predicted by
computational or in vitro biochemical analysis, for viral
RNA dimerization using our in-virion assay system
(Figure 4 and Supplementary Figure S2) (26). Figure 4A
illustrates a schematic diagram of the DLS and stems
analyzed in this report. The importance of the long
stem, which establishes the BMH form (U5-AUG stem),
was examined by multiple experiments (Figure 4B and C).
The 2-base substitution at the 30-end of the U5-AUG stem
resulted in a reduction in dimerization abilities (Figure 4B,
Figure 3. Demonstration of a novel long-range interaction within the DLS. (A) DLS sequence alignment of nine HIV-1 subtypes and SIVcpz. PBS
and DIS are presented as shaded. The evolutionarily-conserved complementary sequences are in blue boxes (GCGUC) and green boxes (GACGC).
(B) The sequence of base substitution mutants. The bases for mutation are shown in bold. The G to U substitutions at the 30-end are an inevitable
change for silent mutation for S4m3, although the G is not included in the DLS in this report. Thus, we introduced a 4-base substitution in the
compensatory mutant (S4m3PK). (C) Dimerization ability of the mutants. Results are the average of at least three independent experiments
with SEM. (D) Replication of DLS mutants. Growth curves of two sets of 1-base substitution and compensatory mutants are shown. Data are
representative of three independent experiments.
5016 Nucleic Acids Research, 2012,Vol.40, No. 11S4m8 and m9) and compensatory mutations did not
rescue the ability (Figure 4B, S4m10). On the other
hand, a 2-base substitution in 50-end of the stem triggered
a mild reduction in dimerization (Figure 4B, S4m11).
To better understand the role of the 50-end of the DLS,
2-, 4- and 6-base deletions were introduced. The 2-base
deletion showed a mild effect, whereas the 4- and 6-base
deletions nearly abolished dimerization activity com-
pletely (Figure 4B, 50d2, 50d4 and 50d6). We next
examined the importance of duplex formation at the top
of the U5-AUG stem (Figure 4C). A single base substitu-
tion of G to C, or C to G, reduced dimerization activity,
and respective compensatory substitutions fully recovered
dimerization activity. Taken together, these results
strongly suggest that the top stem of the U5-AUG struc-
ture was functionally important for the DLS structure.
The functional importance of the PBS and SL3 stem
base pairings were also explored. Of the three potential
base-pairings analyzed around the PBS stem, only one
of the base-pairings (Figure 4D: P2-P2C) conﬁrmed to
be important for DLS structure, as evidenced by the
loss- and gain-of-function mutagenesis studies. Similarly,
within the SL3, base pairing of the stem was proved to
be functionally required (Figure 4E).
The computer-aided modeling of the DLS 3D structure
Upon the accumulated results, we draw the
two-dimensional (2D) structural schema of DLS
(Figure 5A). The 2D schema shows that the DLS is
characterized by a unique pseudoknot-like conformation
and three stem–loops. Such a pseudoknot-like conform-
ation was predicted to form upon performing secondary
structure prediction analysis using MC-Fold, without
using additional experimental information. We further
attempted the 3D structural modeling of the DLS by
using RNA structure prediction computer programs that
have shown marked improvements as of recent. We then
conﬁrmed whether the DLS could indeed have conform-
ations similar to our modeling, without unfavorable
interactions such as steric clash. The modeling predicted
only two plausible 3D structures of the DLS monomer
having the pseudoknot-like conformation (Figure 5B
Figure 4. Conﬁrmation of the stem formations within the DLS. (A) Schematic representations of the stems in HIV-1 DLS studied in this report.
The speciﬁc positions examined are enclosed with rectangles and tagged with capitals. (B–E) The dimerization assay of the mutants. Upper tables
describe the mutations introduced. Hyphens represent base deletions. Lower graphs represent dimerization ability of the mutants. Results are the
average of at least three independent experiments with SEM.
Nucleic Acids Research, 2012,Vol.40, No. 11 5017and C). In each of the DLS structures, the SL1 loop neigh-
bored the SL3 loop and the pseudoknot-like conformation
was located near the bases of these loops. In contrast, the
two structures had distinct PBS stem orientations.
Furthermore, we constructed dimer predictions based
on these monomer structures (Figure 5D and E). In the
dimer structures, palindromic sequences within the SL1
had interactions between monomers, whereas the
pseudoknot-like conformations were furthest apart from
each other. We also predicted 3D structural models of
the DLS without a connection region between SL3 and
the 30-end part of the pseudoknot-like conformation. The
modeling continually generated more structures, suggest-
ing the pseudoknot-like conformation in the DLS would
restrict its conformation. In the two models, an AUG
codon at the translation initiation site of Gag p17 ORF
formed a ‘U5-AUG duplex’, which was embedded as
unexposed, translation-incompetent structures.
DISCUSSION
The retroviral RNA genome dimerization is an essential
event for the viral lifecycle, especially for genome
packaging, reverse transcription and recombination.
Thus, the genome dimerization signal (DLS) of HIV-1
could be a probable target for anti-retroviral therapy.
Although the DLS on the RNA strand is known to be
located at the 50-end of the genome, its precise sequence
and its functional structure has never been determined.
We previously developed a unique analysis system to
Figure 5. New models of 2D and 3D structure of the DLS. The 2D and 3D structures of the DLS. (A) The 2D DLS schematic model that contains a
previously unknown GCGUC-GACGC duplex. Other duplexes that were proposed previously and suggested to play roles in HIV-1 RNA dimer-
ization within the virion in this and other studies (12,41) are also indicated. (B, C) Two 3D structural models of the DLS monomer. The 3D
structural models of the DLS monomer were predicted with the MC-Sym software (37) by incorporating information on the duplexes within the DLS
described in Figure 5A. Only two monomer models that were thermodynamically stable were obtained, due to the pseudoknot-like conformation that
was formed with the two duplexes (GCGUC-GACGC and U5-AUG) restraining the conformational ﬂexibility of the monomer. (D, E) Two 3D
structural models of the DLS dimer. The 3D structural models of the DLS dimer were constructed by superposing 3D structure of SL1 with SL1 in
a reported dimer structure [PDB code: 2D19 (24)], followed by energy minimization as described in ‘Materials and Methods’ section.
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HIV-1 virion (1) (Figure 1A and B). This assay is very
sensitive and even subtle mutations within the DLS are
often detectable, as mutations dramatically alter RNA
dimerization abilities. Through this system, we determined
entire functional sequences that are required for mediating
the RNA–RNA interactions within the HIV-1 virion (26).
We built upon our previous observations and attempted
to determine the DLS functional structure through loss-
and gain-of-function studies using site-directed mutagen-
esis. We initially tried to choose the right structural model
from two previously proposed models (BMH and SL4),
but were unsuccessful in fully restoring the WT dimeriza-
tion phenotype (Figure 2). All base substitution mutations
on either 50-o r3 0-end of the DLS, as well as the deletion of
the 30-end crippled dimerization abilities, and we were
unable to conﬁrm a deﬁnitive stem formation. The data
suggested that the 30-end of the DLS is responsible for
viral RNA dimerization in vivo. On the other hand,
mutations in the 50-end of DLS also notably affected
dimerization abilities. As both the 30-end region in the
BMH model and the 50-end region in the SL4 form do
not contribute to maintain the overall DLS structure,
these existing models may not fully represent the actual
DLS structure. Thus, it was necessary to explore a new
structural model to better compensate for the conﬂicts
apparent in the previous models. In the northern blots
of Figure 2, there are several lower migrating bands
than viral RNA dimers. We believe they represent heter-
ologous form(s) of viral genome dimer. In our recent
report, we noted that the viral RNA proﬁles transform
variously during maturation (3), thus under certain
conditions, it is plausible that viral RNAs could form
heterologous proﬁles.
We next tried to get further insight into the importance
of the 30-end of the DLS by searching for nucleotide
sequence conservation among variants of HIV-1
(Figure 3A). As expected, complete conservation of the
SL4 region (downstream of AUG) was found with nine
HIV-1 subtypes and SIVcpz. In addition, we discovered
a completely conserved 5-base sequence upstream of SL1
(GACGC), which formed a perfect complementary
base paring with the DLS 30-end sequence (GCGUC). It
is conceivable that these two areas form a previously
unknown stem structure (GCGUC-GACGC duplex).
Therefore, we performed mutational analysis to assess
the functionality of this base-pairing using genome dimer-
ization and viral viability assays (Figure 3B–D). All mu-
tations that disrupted this base pairing severely reduced
DLS activities and viral replication abilities, whereas
subsequent corrections of these mutations fully restored
DLS activity and viral replication. These results strongly
suggest that the GCGUC-GACGC duplex plays very
important roles for DLS function.
Our consecutive exploration to determine DLS struc-
ture resulted in the accumulation of informative data
(Figure 4). The data suggested the existence of important
structures in the upper portion of the U5-AUG stem, a
part of the PBS stem and the SL3 stem. Additionally, the
data also suggested the importance of the DLS 50-end
(Figuure 4B, DDNd2-50d2, d4 and d6) and the base just
downstream of the PBS stem (Figure 4D, DDNd2P3),
although the structural status of those bases remains
unknown.
From these data, we constructed a 2D DLS schematic
model which contained a pseudoknot-like conformation
and three stem–loops (Figure 5A). We further attempted
to construct a 3D structural model through in silico
analysis. The modeling predicted only two plausible
monomer models and two corresponding dimer models,
due to limitations imposed by steric restriction from the
pseudoknot-like conformation. In those two models,
conformations and orientations of the SL1 and SL3
pseudoknot-like regions were similar to each other. This
suggests that the pseudoknot-like conformation would be
solid, and formed a foundational skeleton for the
DLS to maintain each angle of stem–loops, including SL1.
Several studies were published reporting on the HIV-1
packaging signal (psi) and DLS (psi/DLS) structural
models (10,14,25,33,34,43,44). However, none of the
works predicted the stem formation of the GCGUC-GA
CGC duplex reported here, and we believe there are
several reasons to explain this discrepancy. First, some
models were originated by in vitro experiments
(14,25,43,44). As HIV-1 RNA dimerization and packaging
occurs during virion production, Gag– and/or GagPol–
RNA binding is believed to be one of the essential steps
for RNA dimerization and DLS formation (3,45–47).
Thus, even in the presence of exogenous viral nucleocapsid
(NC) or Gag proteins in the reaction, the conditions for
RNA folding in vitro would not be the same as in vivo.
These subtle differences may mask, or cause oversight,
details of these interactions that were unexpected.
Second, other reports were based on the results of
chemical or enzymatic probing of viral RNA in vivo
(10,33,34). These RNA probing analyses basically
provide us with the information of single- or double-
stranded RNA formation tendencies within the RNA
strand, yet no information on speciﬁc stem formation. It
should be noted that SHAPE analysis-based structural
modeling still depends on empirical and predictive
computer calculations, which are susceptible to the
aforementioned discrepancies. In fact, most of the bases
in GACGC-GCGUC were unresponsive to probing in
some of the previous reports (33,34), suggesting the stem
formation could occur between these strands. The SHAPE
analysis we performed in which we targeted the duplex
with ex virion RNA (Supplementary Figure S3A) recon-
ﬁrmed previous reports that the overall SHAPE reactivity
of duplex forming bases was very low. It was not
surprising that the duplex reactivity of the mutants was
not signiﬁcantly affected, as the mutations only disrupt
one out of ﬁve possible base pairings. In addition, the
viral RNA dimerization status of the destabilizing
mutants looked unchanged in the viral particle
(Supplementary Figure S3C). Slight elevations in reactiv-
ity that were observed at the counterpart of each mutated
stem in the destabilizing mutant (GACGC of S4m1 and G
CGUC of C236G) might reﬂect the reduction in mutant
viability (Figure 3D). To pursue and conﬁrm this inter-
action, as well as the proposed 3D model, additional
in vitro experiments might be beneﬁcial such as
Nucleic Acids Research, 2012,Vol.40, No. 11 5019cross-linking [as in (44)], NMR [as used in (25)] or/and
ﬂuorescence resonance energy transfer (FRET) experi-
ments providing distance constraints [for a review, (48)].
We do not rule out the possibility of many RNA–RNA
interactions presented hitherto. As we mentioned in our
previous reports (1,26), we assume that RNA dimerization
is one of the multiple steps involved in RNA packaging,
and that psi/DLS RNA must be recognized as an intact
packaging signal by viral protein only after a secondary or
higher structure is composed by two psi/DLS molecules.
Within the cytoplasm of virus producing cell, non-speciﬁc
Gag–viral RNA binding would occur just after Gag
translation. If that were indeed the case, transient RNA
secondary structure formation and/or Gag–RNA
interaction would be continually required to form the
accurate DLS through a trial-and-error process. During
this process, various stem formations would be possible,
and the suggested stems in previous reports, such as SL4
(12) or GACGC and the lower part of SL1 (33,34),
might exist transiently.
According to our previous data, SL2 is dispensable for
RNA dimerization in virion (26). This does not mean that
SL2 is unnecessary for RNA packaging, as we repeatedly
mentioned that genome packaging process would require
additional steps other than genome dimerization for
completion. Indeed, certain RNA regions outside DLS
such as SL2 were reported to be required for genome
encapsidation (17,18,31), suggesting SL2 could be
required for formation of psi, which is larger than and
wholly involves DLS. SL2 region showed high conserva-
tion and GC-rich proﬁles (Figure 3A), which may suggest
it as a target for a stem formation other than SL2 during
psi construction. Moreover, SL2 is deﬁnitely essential for
viral RNA splicing, thus its sequence must be highly
conserved for solid structure formation of SL2.
We mainly discussed a potential of intra-strand
long-range RNA–RNA interaction in the 50-UTR of
HIV-1. However, based on presented results, this inter-
action could also involve inter-strand RNA interactions
(within a dimer of viral RNA). The dimerization assay
we performed (Figures 2, 3 and 4) only validated
intra-strand interactions since loss-and-gain mutations
were introduced in one DLS of the constructs. On the
other hand, the results of viral replication assay and
SHAPE analysis could reﬂect both intra- and inter-strand
interactions. During virion maturation, dimerized DLS is
suggested to change its form from kissing-loop to
extended-duplex by the action of the NC protein (49).
Elongation of extended-duplex form might result in the
inter-strand encounter between long-range interaction
sites. Further analysis focusing on inter-strand base
pairing may give us unforeseen possibility of DLS
structure.
There are several reports suggesting viral RNA
pseudoknot formations [for a review, (50)] and their im-
portance in viral replication have been well discussed.
However, most of the reported studies focus on internal
ribosomal entry site (IRES) formulations or ribosomal
frameshifts. Although there was a report describing long
range pseudoknot in the 50-untranslated and MA coding
regions of HIV-1 genomic RNA (51), it was in vitro study
with partial RNA fragments. As far as we know, this is the
ﬁrst report suggesting that the RNA pseudoknot-like con-
formation is essential to maintain viral genome dimeriza-
tion in virion and subsequent viral replication.
In conclusion, we discovered a long-range interaction
within the HIV-1 DLS which has been previously un-
noticed and successfully constructed novel 3D models of
the DLS through in silico modeling. The structure around
this long-range interaction was very conserved and formed
a solid pseudoknot-like conformation; therefore its unique
shape could be an attractive target for novel anti-HIV
therapies. So far, the development of anti-HIV drugs
that target RNA dimerization has been dominated by
the DIS site (52–55), therefore the characteristic viral
RNA structure presented here could be a good target
candidate for multi-drug therapy strategies. Further
investigation of both the function and structure of the
DLS would be required for effective drug development,
as well as a better understanding of the viral life cycle.
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